Inactive Instrument
Quotes Onyx Pharmaceuticals, Inc.
Stocks
US6833991093
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 27/08/13 | Gilead Sciences, Inc. : Bradway's patient dealmaking brings Onyx to Amgen | RE |
| 26/08/13 | Onyx Pharmaceuticals, Inc. : Onyx deal expected to give Amgen a big boost | RE |
Stock exchange
Nasdaq- $
-
0
$
| Markets | Price | Change | Volumes |
|---|
Basic data
Market Cap (USD)
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 0 | |
| -1.59% | -3.35% | +64.49% | +98.69% | 69.54B | |
| -1.34% | -0.75% | +48.56% | +90.63% | 64.97B | |
| -8.37% | -12.43% | +0.14% | -15.42% | 25.64B | |
| -2.35% | -5.75% | -12.17% | +448.29% | 25.89B | |
| +0.30% | -0.69% | +63.18% | +11.93% | 26.51B | |
| -0.96% | +10.36% | +278.86% | +438.78% | 20.22B | |
| -0.51% | +0.23% | +33.71% | -18.02% | 19.98B | |
| -1.91% | -4.37% | +13.33% | +531.29% | 15.69B | |
| -1.47% | +0.68% | +43.67% | +145.49% | 13.49B | |
| Average | -2.02% | -1.93% | +59.31% | +192.41% | 28.19B | |
| Weighted average by Cap. | -1.93% | -1.50% | +57.15% | +152.82% |
Historical Quotes: Onyx Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- Stock
- Quotes Onyx Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
